Executives Put Money to Work: Uber COO Leads Fresh Buying Wave

The latest insider filings, reported on 8 September, show a split picture across global markets. Discretionary purchases are grabbing attention at UBER, while heavy selling hit a South Korean robotics name.

UBER President and COO Andrew Gordon MacDonald filed purchases totalling roughly $5.3 million. The trades were made on 4 September. This is open-market buying by a senior operator, not a compensation grant. That makes it a stronger signal than routine executive awards.

Across global markets, Burçelik Vana Chairman Umit Gumus filed a $12.9 million purchase in the Turkish industrial company on 7 September. Chairman-level open-market buying at that scale stands out. It suggests conviction at the very top.

On the sell side, Kim Byeong Soo, CEO of South Korean robotics firm ROBOTIS, filed a $75 million sale on 8 September. The significance score on this transaction is low, which may point to a pre-arranged plan rather than a discretionary decision. Readers should treat it accordingly.

In drug trials, ZBIO Zenas BioPharma's trial completion date slippage moved 2.2 standard deviations below its own history as of 13 October, per ORTEX alt data. That flags an unusually sharp schedule acceleration, which could reduce execution risk ahead of any future catalyst.

Activist filings via Schedule 13D were not available in this data window. Stakes disclosed in 13D filings are as-last-disclosed around the 5% threshold and can change without further notice.